Clinical Trials Directory

Trials / Completed

CompletedNCT01750723

Acetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow

Basic Research on Acetazolamide´s Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow in a Humane Experimental Headache Model

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

In this study the investigators will research the hypothesis that the drug Acetazolamide induce headache and dilation of cerebral arteries and increase the cerebral blood flow in the areas of the brain supplied by these arteries.

Detailed description

To investigate headache score and accompanying symptoms during and after infusion of acetazolamide. With magnetic resonance imaging the investigators will investigate changes in regional cerebral blood flow (rCBF) in the area supplied by middle cerebral artery (MCA), diameter of MCA, the Internal carotic artery (ICA), the superficial temporal artery (STA) and the Medial Meningeal artery (MMA).

Conditions

Interventions

TypeNameDescription
DRUGAcetazolamide1 g diluted in 10 ml saline, i.v. bolus injection.

Timeline

Start date
2012-12-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2012-12-17
Last updated
2013-07-09

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01750723. Inclusion in this directory is not an endorsement.